October 27, 2015 FDA approves Amgen's heart-failure drug Corlanor The U.S. Food and Drug Administration on Wednesday approved Amgen Inc.’s heart-failure treatment Corlanor, which had been designated for priority review in August.
October 27, 2015 Baby boomer? Don’t skip this vital screening Millions of baby boomers have an infection and don’t even know it. It often doesn’t show its ugly face until internal damage has already been done and liver cirrhosis has set in.
October 27, 2015 Untested stimulant drug found in 12 supplements A new stimulant drug that has never been tested in people can be found in 12 weight loss and sports supplements, some of which are sold in mainstream vitamin shops, according to a new study
October 27, 2015 Brain 'folds' may predict if drugs will help psychosis The extent of "folds" on the outer layer of the brain could give doctors a clue as to how well people suffering problems such as hallucinations or delusions will respond to antipsychotic drugs.
October 27, 2015 FDA outlines plan to combat drug shortages The U.S. Food and Drug Administration released a strategic plan for preventing drug shortages on Thursday and proposed a rule to require drug and biotechnology companies to promptly notify the agency of potential disruptions to the supply of medically important drugs.
October 27, 2015 New drugs treat advanced stages of a common skin cancer The most commonly-occurring cancer in the U.S. is basal-cell carcinoma, a type of skin cancer that is often treated with surgery or other procedures, and rarely fatal.
October 27, 2015 Statin side effects can often be overcome, study finds Most people who stop taking cholesterol-lowering statins - because of side effects or for another reason - are able to restart the same drug or a similar one without lasting problems, a new study suggests
October 27, 2015 Spain court backs ruling for German firm in thalidomide case Spain's Supreme Court has upheld a lower court ruling that a German pharmaceutical company does not have to pay compensation to 22 Spaniards who blame their disabilities on the drug thalidomide.
October 27, 2015 Expensive new heart medications: When are they worth it? Newly approved drugs for heart failure and high cholesterol come with raised expectations and, in some cases, alarmingly high prices.
October 27, 2015 FDA approves Eisai's thyroid cancer drug The U.S. Food and Drug Administration said it approved Japan's Eisai Co Ltd's drug to treat the most common form of thyroid cancer.
